Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exogenous Luteinizing Hormone Supplementation to Improve Embryo Quality in Patients With Excessive LH Suppression During a Long GnRH-Agonist Protocol: A Randomized Controlled Trial

NCT07128394 is registered in ClinicalTrials.gov with Nanjing University as lead sponsor.

NCT NCT07128394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07128394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exogenous Luteinizing Hormone Supplementation to Improve Embryo Quality in Patients With Excessive LH Suppression During a Long GnRH-Agonist Protocol: A Randomized Controlled Trial
Lead sponsor
Nanjing University
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2024
Completion date
November 30, 2026
Enrollment
590 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female, luteinizing hormone (lh)